These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 18353370

  • 1. Evaluation of treatment response in depression studies using a Bayesian parametric cure rate model.
    Santen G, Danhof M, Della Pasqua O.
    J Psychiatr Res; 2008 Oct; 42(14):1189-97. PubMed ID: 18353370
    [Abstract] [Full Text] [Related]

  • 2. Does early improvement triggered by antidepressants predict response/remission? Analysis of data from a naturalistic study on a large sample of inpatients with major depression.
    Henkel V, Seemüller F, Obermeier M, Adli M, Bauer M, Mundt C, Brieger P, Laux G, Bender W, Heuser I, Zeiler J, Gaebel W, Mayr A, Möller HJ, Riedel M.
    J Affect Disord; 2009 Jun; 115(3):439-49. PubMed ID: 19027961
    [Abstract] [Full Text] [Related]

  • 3. Placebo response and antidepressant clinical trial outcome.
    Khan A, Detke M, Khan SR, Mallinckrodt C.
    J Nerv Ment Dis; 2003 Apr; 191(4):211-8. PubMed ID: 12695731
    [Abstract] [Full Text] [Related]

  • 4. Relationship between depression severity entry criteria and antidepressant clinical trial outcomes.
    Khan A, Schwartz K, Kolts RL, Ridgway D, Lineberry C.
    Biol Psychiatry; 2007 Jul 01; 62(1):65-71. PubMed ID: 17141744
    [Abstract] [Full Text] [Related]

  • 5. A comparative meta-analysis of Clinical Global Impressions change in antidepressant trials.
    Spielmans GI, McFall JP.
    J Nerv Ment Dis; 2006 Nov 01; 194(11):845-52. PubMed ID: 17102709
    [Abstract] [Full Text] [Related]

  • 6. Sensitivity of the Montgomery Asberg Depression Rating Scale to response and its consequences for the assessment of efficacy.
    Santen G, Danhof M, Della Pasqua O.
    J Psychiatr Res; 2009 Aug 01; 43(12):1049-56. PubMed ID: 19344914
    [Abstract] [Full Text] [Related]

  • 7. Using longitudinal data from a clinical trial in depression to assess the reliability of its outcome scales.
    Laenen A, Alonso A, Molenberghs G, Vangeneugden T, Mallinckrodt CH.
    J Psychiatr Res; 2009 Apr 01; 43(7):730-8. PubMed ID: 18986657
    [Abstract] [Full Text] [Related]

  • 8. Efficacy of imipramine in psychotic versus nonpsychotic depression.
    Birkenhager TK, van den Broek WW, Mulder PG, Moleman P, Bruijn JA.
    J Clin Psychopharmacol; 2008 Apr 01; 28(2):166-70. PubMed ID: 18344726
    [Abstract] [Full Text] [Related]

  • 9. Redistribution of slow wave activity of sleep during pharmacological treatment of depression with paroxetine but not with nefazodone.
    Argyropoulos SV, Hicks JA, Nash JR, Bell CJ, Rich AS, Nutt DJ, Wilson S.
    J Sleep Res; 2009 Sep 01; 18(3):342-8. PubMed ID: 19549078
    [Abstract] [Full Text] [Related]

  • 10. Superiority of escitalopram to paroxetine in the treatment of depression.
    Kasper S, Baldwin DS, Larsson Lönn S, Boulenger JP.
    Eur Neuropsychopharmacol; 2009 Apr 01; 19(4):229-37. PubMed ID: 19185467
    [Abstract] [Full Text] [Related]

  • 11. A randomized controlled trial of sertraline for the treatment of depression in persons with traumatic brain injury.
    Ashman TA, Cantor JB, Gordon WA, Spielman L, Flanagan S, Ginsberg A, Engmann C, Egan M, Ambrose F, Greenwald B.
    Arch Phys Med Rehabil; 2009 May 01; 90(5):733-40. PubMed ID: 19406291
    [Abstract] [Full Text] [Related]

  • 12. An examination of 26,168 Hamilton Depression Rating Scale scores administered via interactive voice response across 17 randomized clinical trials.
    Moore HK, Mundt JC, Modell JG, Rodrigues HE, DeBrota DJ, Jefferson JJ, Greist JH.
    J Clin Psychopharmacol; 2006 Jun 01; 26(3):321-4. PubMed ID: 16702899
    [Abstract] [Full Text] [Related]

  • 13. Mirtazapine and paroxetine in major depression: a comparison of monotherapy versus their combination from treatment initiation.
    Blier P, Gobbi G, Turcotte JE, de Montigny C, Boucher N, Hébert C, Debonnel G.
    Eur Neuropsychopharmacol; 2009 Jul 01; 19(7):457-65. PubMed ID: 19345072
    [Abstract] [Full Text] [Related]

  • 14. Sensitivity of the individual items of the Hamilton depression rating scale to response and its consequences for the assessment of efficacy.
    Santen G, Gomeni R, Danhof M, Della Pasqua O.
    J Psychiatr Res; 2008 Oct 01; 42(12):1000-9. PubMed ID: 18206909
    [Abstract] [Full Text] [Related]

  • 15. Onset of antidepressant action: a pharmacological question?
    Rojo JE, Gibert K, Cobo J, Rodriguez-Cano E, Vallejo J.
    Hum Psychopharmacol; 2005 Aug 01; 20(6):425-33. PubMed ID: 16106477
    [Abstract] [Full Text] [Related]

  • 16. An ideal trial to test differential onset of antidepressant effect.
    Leon AC, Blier P, Culpepper L, Gorman JM, Hirschfeld RM, Nierenberg AA, Roose SP, Rosenbaum JF, Stahl SM, Trivedi MH.
    J Clin Psychiatry; 2001 Aug 01; 62 Suppl 4():34-6; discussion 37-40. PubMed ID: 11229787
    [Abstract] [Full Text] [Related]

  • 17. Improving the estimation of change from baseline in a continuous outcome measure in the clinical trial setting.
    Mayer-Hamblett N, Kronmal RA.
    Contemp Clin Trials; 2005 Feb 01; 26(1):2-16. PubMed ID: 15837448
    [Abstract] [Full Text] [Related]

  • 18. The persistence of the placebo response in antidepressant clinical trials.
    Khan A, Redding N, Brown WA.
    J Psychiatr Res; 2008 Aug 01; 42(10):791-6. PubMed ID: 18036616
    [Abstract] [Full Text] [Related]

  • 19. The missing link between clinical endpoints and drug targets in depression.
    Della Pasqua O, Santen GW, Danhof M.
    Trends Pharmacol Sci; 2010 Apr 01; 31(4):144-52. PubMed ID: 20117847
    [Abstract] [Full Text] [Related]

  • 20. A kinetic-pharmacodynamic model for clinical trial simulation of antidepressant action: application to clomipramine-lithium interaction.
    Gruwez B, Poirier MF, Dauphin A, Olié JP, Tod M.
    Contemp Clin Trials; 2007 May 01; 28(3):276-87. PubMed ID: 17059901
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.